Search research articles
Contact Us
Filters
Showing results (31-40 of 485) with videos related to
Page
of 49
Sort By:
JACC. Basic to Translational Science
|
November 27, 2019
The Detrimental Effects of Alcohol and Cannabinoids on Cardiovascular Function
Fabrizio Montecucco, Federico Carbone
Current Medicinal Chemistry
|
December 29, 2021
Osteopontin in CardioMetabolic Medicine: A Risk Stratification Biomarker with Future Therapeutic Implication
Federico Carbone, Fabrizio Montecucco
European Journal of Clinical Investigation
|
June 9, 2020
Adipocytokines and cardiovascular diseases: Putative role of Neuregulin 4
Luca Liberale, Fabrizio Montecucco
Thrombosis and Haemostasis
|
October 21, 2011
Should we focus on "venous vulnerability" instead of "plaque vulnerability" in symptomatic atherosclerotic patients?
Fabrizio Montecucco, François Mach
Diabetes Research and Clinical Practice
|
March 14, 2018
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Aldo Bonaventura, Fabrizio Montecucco
Seminars in Immunopathology
|
April 18, 2009
Atherosclerosis is an inflammatory disease
Fabrizio Montecucco, François Mach
World Journal of Hepatology
|
July 19, 2016
Sofosbuvir/velpatasvir: A promising combination
Aldo Bonaventura, Fabrizio Montecucco
Trends in Pharmacological Sciences
|
April 17, 2012
At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction
Fabrizio Montecucco, Vincenzo Di Marzo
European Heart Journal
|
August 16, 2023
Future research with advanced imaging technology and biomarkers
Fabrizio Montecucco, Thomas H Schindler
Frontiers in Cardiovascular Medicine
|
September 12, 2022
Physical activity to reduce PCSK9 levels
Amedeo Tirandi, Fabrizio Montecucco, Luca Liberale
Page
of 49
Search research articles
Search
Showing results (31-40 of 485) with videos related to
Sort By:
Page
of 49
JACC. Basic to Translational Science
|
November 27, 2019
The Detrimental Effects of Alcohol and Cannabinoids on Cardiovascular Function
Fabrizio Montecucco, Federico Carbone
Current Medicinal Chemistry
|
December 29, 2021
Osteopontin in CardioMetabolic Medicine: A Risk Stratification Biomarker with Future Therapeutic Implication
Federico Carbone, Fabrizio Montecucco
European Journal of Clinical Investigation
|
June 9, 2020
Adipocytokines and cardiovascular diseases: Putative role of Neuregulin 4
Luca Liberale, Fabrizio Montecucco
Thrombosis and Haemostasis
|
October 21, 2011
Should we focus on "venous vulnerability" instead of "plaque vulnerability" in symptomatic atherosclerotic patients?
Fabrizio Montecucco, François Mach
Diabetes Research and Clinical Practice
|
March 14, 2018
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Aldo Bonaventura, Fabrizio Montecucco
Seminars in Immunopathology
|
April 18, 2009
Atherosclerosis is an inflammatory disease
Fabrizio Montecucco, François Mach
World Journal of Hepatology
|
July 19, 2016
Sofosbuvir/velpatasvir: A promising combination
Aldo Bonaventura, Fabrizio Montecucco
Trends in Pharmacological Sciences
|
April 17, 2012
At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction
Fabrizio Montecucco, Vincenzo Di Marzo
European Heart Journal
|
August 16, 2023
Future research with advanced imaging technology and biomarkers
Fabrizio Montecucco, Thomas H Schindler
Frontiers in Cardiovascular Medicine
|
September 12, 2022
Physical activity to reduce PCSK9 levels
Amedeo Tirandi, Fabrizio Montecucco, Luca Liberale
Page
of 49